Pagsiat, Czymon Brian L.

HRN: 20-55-82  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/15/2022
AMPICILLIN 500MG (VIAL)
06/15/2022
06/21/2022
IVT
280 MG
Q8
UTI
Waiting Final Action 
06/15/2022
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
06/15/2022
06/21/2022
PO
4.5 Ml
TID
Amoebiasis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: